Cancer

Cover image for Vol. 123 Issue 19

Edited By: Fadlo R. Khuri, MD

Impact Factor: 6.072

ISI Journal Citation Reports © Ranking: 2016: 35/217 (Oncology)

Online ISSN: 1097-0142

Associated Title(s): Cancer Cytopathology, CA: A Cancer Journal for Clinicians

Highlighted Papers

  • Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas

    Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas

    Patient MRI at study enrollment (top) and after 6 months of therapy (bottom).

  • The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide

    The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide

    Relationship between number of prescriptions and total recipient amount in the Open Payments database for abiraterone and enzalutamide.

  • Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics

    Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics

    An illustration of patients' uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) haplotype status after receiving IMMU-132 along with the incidence of neutropenia or diarrhea based on haplotype.

  • Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer

    Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer

    Proton-beam treatment plan of a 74 year-old female patient with limited-stage small cell lung cancer.

  • Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?

    Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?

    The rationale for the sequential administration of trabectedin followed by platinum compounds.

  • A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults

    A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults

    Morphologic features of hemophagocytosis are observed on a bone marrow aspirate smear.

  • TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens

    TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens

    Tumor protein 53 (TP53) mutations in patients newly diagnosed with acute lymphoblastic leukemia (ALL).

  • Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine

    Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine

    Manhattan plot of SNPs associated with palmar-plantar erythrodysesthesia syndrome after adjustments for ancestry. 

  • Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas
  • The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide
  • Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics
  • Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer
  • Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?
  • A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults
  • TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens
  • Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine

Recently Published Issues

See all

CancerScope

Cancer diagnosis

CancerScope

CancerScope

First Person: Graham Colditz, MD, DrPH

The internationally known epidemiologist and public health expert aims to dispel the idea that developing cancer is beyond one's control.

Click here to read this article
Click here to download the PDF




Stay up-to-date with
Cancer
Like Cancer on FacebookFollow Cancer on TwitterFollow Cancer on Google Follow Cancer on Figure 1

SEARCH

SEARCH BY CITATION